Literature DB >> 9252857

Severe hepatotoxicity on beginning propylthiouracil therapy.

D R Lock1, Z M Sthoeger.   

Abstract

We report a case of propylthiouracil (PTU)-induced cholestatic hepatotoxicity in Graves' disease that developed 1 day after beginning PTU. After clinical recover, liver abnormalities persisted for 5 years. Percutaneous liver biopsy and the eventual normalization of enzyme levels excluded permanent liver damage as a result of PTU therapy. Thus prolonged elevation of serum enzymes is consistent with the diagnosis of PTU-induced hepatotoxicity, which may recover completely.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252857     DOI: 10.1097/00004836-199706000-00020

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?

Authors:  M Benyounes; C Sempoux; C Daumerie; J Rahier; A P Geubel
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 2.  Liver failure due to antithyroid drugs: report of a case and literature review.

Authors:  Sarantis Livadas; Xenofon Xyrafis; Frangiskos Economou; Georgios Boutzios; Maria Christou; Aristea Zerva; Athanasios Karachalios; Helen Palioura; Sotiria Palimeri; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2010-05-18       Impact factor: 3.925

3.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.